|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beadsmoore CJ and Screation NJ:
Classification, staging and prognosis of lung cancer. Eur J Radiol.
45:8–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goldstraw P, Crowley J, Chansky KJ, et al:
The IASLC Lung Cancer Staging Project: proposals for the revision
of the TNM stage groupings in the forthcoming (seventh) edition of
the TNM classification of malignant tumours. Thorac Oncol.
2:706–714. 2007. View Article : Google Scholar
|
|
4
|
Marchesani W: Über den primären
Bronchialkrebs. Frankf Z Path. 30:158–190. 1924.(In German).
|
|
5
|
Kayser K, Bauer A, David H and Kayser G:
Historical aspects of pulmonary pathology with specific emphasis on
ancient reports. Electronic Journal of Pathology and Histology.
9.2:32–37. 2003.
|
|
6
|
Travis WD, Brambilla E, Müller-Hermelin HK
and Harris CC; World Health Organization Classification of Tumours.
Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and
Heart. IARC Press; Lyon: 2004
|
|
7
|
Hong J, Kyung SY, Lee SP, et al:
Pemetrexed versus gefitinib versus erlotinib in previously treated
patients with non-small cell lung cancer. Korean J Intern Med.
25:294–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rossi A, Ricciardi S, Maione P, de Marinis
F and Gridelli C: Pemetrexed in the treatment of advanced
non-squamous lung cancer. Lung Cancer. 66:141–149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sandler A, Gray R, Perry MC, et al:
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell
lung cancer. N Engl J Med. 355:2542–2550. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reck M, von Pawel J, Zatloukal P, et al:
Phase III trial of cisplatin plus gemcitabine with either placebo
or bevacizumab as first-line therapy for nonsquamous non-small-cell
lung cancer: AVAil. J Clin Oncol. 27:1227–1234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rosell R, Perez-Roca L, Sanchez JJ, et al:
Customized treatment in non-small-cell lung cancer based on EGFR
mutations and BRCA1 mRNA expression. PLoS One. 4:e51332009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okada K, Kijima H, Imaizumi T, et al:
Wall-invasion pattern correlates with survival of patients with
gallbladder adenocarcinoma. Anticancer Res. 29:685–691.
2009.PubMed/NCBI
|
|
13
|
Song KY, Hur H, Jung CK, et al: Impact of
tumor infiltration pattern into the surrounding tissue on prognosis
of the subserosal gastric cancer (pT2b). Eur J Surg Oncol.
36:563–567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kong KY, Park JY, Kim DY, et al:
Prognostic significance of stromal microinvasion in the intestinal
type of ovarian mucinous adenocarcinoma. Ann Surg Oncol.
18:3462–3468. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morodomi T, Isomoto H, Shirouzu K,
Kakegawa K, Irie K and Morimatsu M: An index for estimating the
probability of lymph node metastasis in rectal cancers. Lymph node
metastasis and the histopathology of actively invasive regions of
cancer. Cancer. 63:539–543. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ueno H, Murphy J, Jass JR, Mochizuki H and
Talbot IC: Tumour ‘budding’ as an index to estimate the potential
of aggressiveness in rectal cancer. Histopathology. 40:127–132.
2002.
|
|
17
|
Nakanishi Y, Ohara M, Doumen H, Kimura N,
Ishidate T and Kondo S: Correlation between tumor budding and
post-resection prognosis in patients with invasive squamous cell
carcinoma of the thoracic esophagus. World J Surg. 35:349–356.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohike N, Coban I, Kim GE, et al: Tumor
budding as a strong prognostic indicator in invasive ampullary
adenocarcinomas. Am J Surg Pathol. 34:1417–1424. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Huang H, Huang Z, et al: Tumor
budding correlates with poor prognosis and epithelial-mesenchymal
transition in tongue squamous cell carcinoma. J Oral Pathol Med.
40:545–551. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sarioglu S, Acara C, Akman FC, et al:
Tumor budding as a prognostic marker in laryngeal carcinoma. Pathol
Res Pract. 206:88–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamaguchi Y, Ishii G, Kojima M, et al:
Histopathologic features of the tumor budding in adenocarcinoma of
the lung: tumor budding as an index to predict the potential
aggressiveness. J Thorac Oncol. 5:1361–1368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumors. 7th edition. Wiley;
Hoboken, NJ: 2009
|
|
23
|
Japanese Gastric Cancer Association.
Japanese Classification of Gastric Carcinoma - 2nd English Edition.
Gastric Cancer. 1:10–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maehara Y, Oshiro T, Adachi Y, Ohno S,
Akazawa K and Sugimachi K: Growth pattern and prognosis of gastric
cancer invading the subserosa. J Surg Oncol. 55:203–208. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haraguchi M, Yamamoto M, Saito A, et al:
Prognostic value of depth and pattern of stomach wall invasion in
patients with an advanced gastric carcinoma. Semin Surg Oncol.
10:125–129. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hase K, Shatney C, Johnson D, Trollope M
and Vierra M: Prognostic value of tumor ‘budding’ in patients with
colorectal cancer. Dis Colon Rectum. 36:627–635. 1993.
|
|
27
|
Maeshima AM, Maeshima A, Asamura H and
Matsuno Y: Histologic prognostic factors for small-sized squamous
cell carcinomas of the peripheral lung. Lung Cancer. 52:53–58.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prall F: Tumour budding in colorectal
carcinoma. Histopathology. 50:151–162. 2007. View Article : Google Scholar
|
|
29
|
Shinto E, Tsuda H, Ueno H, et al:
Prognostic implication of laminin-5 gamma 2 chain expression in the
invasive front of colorectal cancers, disclosed by area-specific
four-point tissue microaarays. Lab Invest. 85:257–266. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moriya Y, Niki T, Yamada T, Matsuno T,
Kondo H and Hirohashi S: Increased expression of laminin-5 and its
prognostic significance in lung adenocarcinomas of small size. An
immunohistochemical analysis of 102 cases. Cancer. 91:1129–1141.
2001. View Article : Google Scholar : PubMed/NCBI
|
